Could Hexo Corp (TSX:HEXO) Be in Trouble With Regulators As Well?

A recent report by a short-seller suggests that Hexo Corp (TSX:HEXO)(NYSE:HEXO) might be the next cannabis stock to run into issues with Health Canada.

| More on:
Businessmen teamwork brainstorming meeting.

Image source: Getty Images

There’s a lot of fear in the cannabis industry in the wake of the CannTrust Holdings scandal. Issues relating to illegal growing there came out of nowhere and sent the stock crashing in just a matter of days.

Then came the news that cannabis giant Curaleaf Holdings in the U.S. was also getting into trouble with the Food and Drug Administration for making some aggressive claims.

These issues have caused a great deal of panic in the industry, and many pot stocks have been struggling over the past month as a result.

One company that’s recently been the target of one short-seller is Hexo Corp (TSX:HEXO)(NYSE:HEXO).

A recent report from The Friendly Bear claims that promotions run by the cannabis operator on Snapchat were “aggressive,” suggesting that they could also run afoul with Health Canada. Using Snapchat is also popular among kids, and if true, that could lead to problems for Hexo.

Could Hexo be the next CannTrust?

The short-seller believes that Hexo could follow in the footsteps of CannTrust, losing a significant amount of its value as a result of the infraction.

However, it should be noted that what CannTrust is accused of doing is illegally growing marijuana, which is on a much different scale than simply promoting their products too aggressively or through the wrong channels.

In Hexo’s situation, products wouldn’t have to be held back to be tested to ensure they’re in compliance with regulations. The company also isn’t being alleged to have misled regulators with respect to how much cannabis it is producing and putting up fake walls to conceal its operations.

Compared to the CannTrust scandal, Hexo is a drop in the bucket. After all, advertisers pushing the limits happens in many industries, not just cannabis; suggesting that Hexo might see a similar drop in share price might therefore be an exaggeration, to say the least.

Health Canada hasn’t indicated the existence of any problems involving Hexo. While it can be unnerving for investors of Hexo, ultimately this is just speculation by a short-seller.

We don’t know whether these claims are valid, and so any concerns surrounding the company may be all for naught. The problem, however, is that if there was confirmation that Hexo was in violation of rules relating to advertising, the stock could go into a free fall very quickly.

Bottom line

It’s a very risky time to be a cannabis investor. Everyone is on the lookout for which company could be the next one to run into regulatory issues, which means that even claims made by a short-seller could send investors into a panic.

The problem is that if investors don’t act on the claims early enough, they could suffer more significant losses if the violations are confirmed to be true. However, if prove to be unfounded, the stock could get a big boost in price.

There’s no way to know for sure — which is making investing in cannabis stocks even riskier today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »